NAS:EPIX (Canada)  
ESSA Pharma Inc logo

ESSA Pharma Inc

$ 1.85 +0.07 (+3.93%) 04:00 PM EST
P/E:
At Loss
P/B:
0.49
Market Cap:
$ 82.45M
Enterprise V:
$ -95.90M
Volume:
26.31K
Avg Vol (2M):
154.68K
Also Trade In:
Volume:
26.31K
Market Cap $:
82.45M
PE Ratio:
At Loss
Avg Vol (2-Month):
154.68K
Enterprise Value $:
-95.90M
PB Ratio:
0.49
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
Name Current Vs Industry Vs History
Cash-To-Debt 721.47
Equity-to-Asset 0.98
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.21
9-Day RSI 16.12
14-Day RSI 20.86
6-1 Month Momentum % -57.55
12-1 Month Momentum % -69.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 43.43
Quick Ratio 43.43
Cash Ratio 43.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -96.7
Name Current Vs Industry Vs History
ROE % -20.04
ROA % -19.62
ROIC % -5968.04
ROC (Joel Greenblatt) % -13860.53
ROCE % -20.02

Financials (Next Earnings Date:2022-11-18 Est.)

EPIX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EPIX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.86
Beta 1.53
Volatility % 78.27
14-Day RSI 20.86
14-Day ATR ($) 0.161605
20-Day SMA ($) 2.201
12-1 Month Momentum % -69.28
52-Week Range ($) 1.66 - 14.88
Shares Outstanding (Mil) 44.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ESSA Pharma Inc Filings

Document Form Filing Date
No Filing Data

ESSA Pharma Inc Analysis

Share your research

Headlines

See More
No news.